-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WzO78p5cjTCwBgX26xrDn/OaIu7dZAml7ywBL1yuuj15WzGOeEAVq+IaohUP/UL8 m4CzGXdIIIoOZun87rBl6A== 0001206369-04-000003.txt : 20040304 0001206369-04-000003.hdr.sgml : 20040304 20040304173845 ACCESSION NUMBER: 0001206369-04-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040303 FILED AS OF DATE: 20040304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 CHIPETA WAY STE 240 CITY: SALT LAKE CITY STATE: UT ZIP: 84108-1256 BUSINESS PHONE: 8015834939 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KLEIN JOSEPH III CENTRAL INDEX KEY: 0001206369 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 04649825 BUSINESS ADDRESS: STREET 1: C/O GENAISSANCE PHARMACEUTICALS INC STREET 2: FIVE SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 2037731450 MAIL ADDRESS: STREET 1: C/O GENAISSANCE PHARMACEUTICALS INC STREET 2: FIVE SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 4 1 edgar.xml PRIMARY DOCUMENT X0201 4 2004-03-03 0000890465 NPS PHARMACEUTICALS INC NPSP 0001206369 KLEIN JOSEPH III 420 CHIPETA WAY SALT LAKE CITY UT 84108 1 0 0 0 Common Stock 2004-03-03 2004-03-03 4 M 0 1000 7.25 A 4100 D Common Stock 2004-03-03 2004-03-03 4 M 0 1000 5.50 A 5100 D Common Stock 2004-03-03 2004-03-03 4 S 0 2000 29.8765 D 3100 D Stock Option 7.25 2004-03-03 2004-03-03 4 M 0 1000 7.25 D 1999-12-01 2008-12-01 Common Stock 1000 0 D Stock Option 5.50 2004-03-03 2004-03-03 4 M 0 1000 5.50 D 2000-12-01 2009-12-01 Common Stock 1000 2000 D This transaction was executed under a Rule 10b5-1 trading plan. James U. Jensen 2004-03-04 -----END PRIVACY-ENHANCED MESSAGE-----